Freddy A. Jimenez insider trades: Celldex Therapeutics (CLDX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Freddy reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | CLDX | ↓ Sell | 4,166 | $29.09 | $121K | Direct | Dec 8, 2025 (4d) |
| Aug 13, 2025 | CLDX | ↓ Sell | 771 | $24.77 | $19K | Direct | Aug 15, 2025 (2d) |
| Jun 3, 2024 | CLDX | ↓ Sell | 8,006 | $33.60 | $269K | Direct | Jun 5, 2024 (2d) |
| Aug 11, 2021 | CLDX | ↑ Buy | 430 | $46.28 | $20K | Direct | Aug 13, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CLDX insiders
Open-market trades in the last 12 months
About Freddy A. Jimenez's insider trades
Freddy A. Jimenez is SVP & General Counsel at Celldex Therapeutics (CLDX). Since Aug 11, 2021, Freddy has reported 1 open-market purchase worth $20K and 3 sales worth $409K on SEC Form 4. In the last 12 months: 1 sale ($121K).
Their filings also include grants and awards (6 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.